Verification evidence is still being completed.
PDF / print export
Anaveon
Basel, Switzerland
- Verified lead
- Dario Neri
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Immunotherapy, Cytokine Engineering, Oncology, Immune Disorders, and Clinical Development
- Review cycle
- May 2026
- Full address
- Basel, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Anaveon contact page confirming the Basel address.
- Editorial note
- Anaveon is published because official company materials confirm current leadership, Basel operating address, and a real cytokine-based immunotherapy platform.
Immunotherapy, Cytokine Engineering, Oncology, Immune Disorders, and Clinical Development
Official leadership disclosure, Official Basel address disclosure, Clinical-stage immunotherapy platform claim
Anaveon is published because official company materials confirm current leadership, Basel operating address, and a real cytokine-based immunotherapy platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Basel, Switzerland
Anaveon
Immunotherapy, Cytokine Engineering, Oncology, Immune Disorders, and Clinical Development · Clinical-stage immunotherapy platform
Anaveon runs cytokine-based drug development, immunotherapy programs, and clinical therapeutics development in Basel, Switzerland.
- Lead
- Dario Neri (verified ↗)
- Address
- Basel, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Clinical-stage immunotherapy platform
- Capabilities
- Cytokine-Based Drug Development · Immunotherapy Programs · Clinical Therapeutics Development
- Founded
- 2017
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Dario Neri
Chief Executive Officer
Full addressBasel, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage immunotherapy platform
Basel, Switzerland. Immunotherapy, Cytokine Engineering, Oncology, Immune Disorders, and Clinical Development. Review completed on 22 Mar 2026.
Swiss corporate and clinical-development oversight
Official leadership disclosure, Official Basel address disclosure, Clinical-stage immunotherapy platform claim
Immunotherapy, Cytokine Engineering, Oncology, Immune Disorders, and Clinical Development
Anaveon is published because official company materials confirm current leadership, Basel operating address, and a real cytokine-based immunotherapy platform.
Editorial note
Anaveon is published because official company materials confirm current leadership, Basel operating address, and a real cytokine-based immunotherapy platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cytokine-Based Drug Development
Immunotherapy Programs
Clinical Therapeutics Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Immunotherapy workflow systems
Clinical program infrastructure
Protein-engineering platform tools
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Anaveon located?
- Anaveon operates from Basel, Switzerland, Basel, Switzerland.
- Who runs Anaveon?
- Anaveon is led by Dario Neri, Chief Executive Officer. Verified 22 Mar 2026.
- What does Anaveon do?
- Anaveon runs cytokine-based drug development, immunotherapy programs, and clinical therapeutics development in Basel, Switzerland. Core capabilities: Cytokine-Based Drug Development, Immunotherapy Programs, Clinical Therapeutics Development.
Editorial context
Related technical briefs
Briefs that name Basel as a covered market or city.